News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
209,136 Results
Type
Article (19941)
Company Profile (114)
Press Release (189070)
Multimedia
Podcasts (42)
Webinars (17)
Section
Business (63716)
Career Advice (837)
Deals (9009)
Drug Delivery (80)
Drug Development (18734)
Employer Resources (146)
FDA (3384)
Job Trends (6098)
News (95141)
Policy (7094)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (1516)
Academic (2)
Accelerated approval (15)
Adcomms (17)
Allergies (41)
Alliances (17372)
ALS (66)
Alzheimer's disease (724)
Antibody-drug conjugate (ADC) (148)
Approvals (3549)
Artificial intelligence (335)
Autoimmune disease (103)
Automation (33)
Bankruptcy (51)
Best Places to Work (4884)
BIOSECURE Act (12)
Biosimilars (78)
Biotechnology (63)
Bladder cancer (55)
Brain cancer (19)
Breast cancer (228)
Cancer (1685)
Cardiovascular disease (188)
Career advice (761)
Career pathing (43)
CAR-T (118)
CDC (26)
Cell therapy (322)
Cervical cancer (13)
Clinical research (15603)
Collaboration (931)
Company closure (1)
Compensation (206)
Complete response letters (21)
COVID-19 (1016)
CRISPR (58)
C-suite (677)
Cystic fibrosis (55)
Data (2525)
Decentralized trials (2)
Denatured (27)
Depression (54)
Dermatology (36)
Diabetes (164)
Diagnostics (2568)
Digital health (20)
Diversity (10)
Diversity, equity & inclusion (37)
Drug discovery (168)
Drug pricing (59)
Drug shortages (6)
Duchenne muscular dystrophy (98)
Earnings (15891)
Editorial (24)
Employer branding (23)
Employer resources (123)
Events (31848)
Executive appointments (640)
FDA (4446)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (9)
Frontotemporal dementia (8)
Funding (856)
Gene editing (108)
Generative AI (32)
Gene therapy (235)
GLP-1 (372)
Government (1427)
Guidances (126)
Healthcare (4985)
HIV (45)
Huntington's disease (24)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (28)
Immunology and inflammation (66)
Immuno-oncology (23)
Indications (51)
Infectious disease (1147)
Inflammatory bowel disease (88)
Inflation Reduction Act (8)
Influenza (45)
Intellectual property (78)
Interviews (120)
IPO (3647)
IRA (17)
Job creations (1314)
Job search strategy (641)
JPM (28)
Kidney cancer (2)
Labor market (94)
Layoffs (205)
Leadership (24)
Legal (1186)
Liver cancer (27)
Longevity (16)
Lung cancer (206)
Lymphoma (166)
Machine learning (28)
Management (43)
Manufacturing (413)
MASH (40)
Medical device (2716)
Medtech (2752)
Mergers & acquisitions (5861)
Metabolic disorders (409)
mRNA (77)
Multiple sclerosis (87)
NASH (9)
Neurodegenerative disease (151)
Neuropsychiatric disorders (27)
Neuroscience (1252)
Neurotech (1)
NextGen: Class of 2026 (2082)
Non-profit (1699)
Now hiring (77)
Obesity (198)
Opinion (145)
Ovarian cancer (55)
Pain (85)
Pancreatic cancer (58)
Parkinson's disease (118)
Partnered (21)
Patents (115)
Patient recruitment (172)
Peanut (17)
People (28484)
Pharmaceutical (24)
Pharmacy benefit managers (2)
Phase 1 (4573)
Phase 2 (6439)
Phase 3 (6156)
Pipeline (2657)
Policy (116)
Postmarket research (556)
Preclinical (2608)
Press Release (61)
Prostate cancer (89)
Psychedelics (28)
Radiopharmaceuticals (78)
Rare diseases (326)
Real estate (2562)
Recruiting (59)
Regulatory (5961)
Reports (46)
Research institute (1316)
Resumes & cover letters (108)
Rett syndrome (3)
RNA editing (11)
RSV (49)
Schizophrenia (61)
Series A (158)
Series B (101)
Service/supplier (7)
Sickle cell disease (45)
Special edition (13)
Spinal muscular atrophy (59)
Sponsored (19)
Startups (2033)
State (1)
Stomach cancer (6)
Supply chain (45)
Tariffs (17)
The Weekly (15)
Vaccines (345)
Venture capital (81)
Weight loss (120)
Women's health (61)
Worklife (20)
Date
Last 7 days (236)
Last 30 days (1007)
Last 365 days (9777)
2026 (4348)
2025 (9649)
2024 (11382)
2023 (12948)
2022 (15524)
2021 (17634)
2020 (16244)
2019 (14946)
2018 (10795)
2017 (10275)
2016 (10148)
2015 (10839)
2014 (7987)
2013 (6913)
2012 (7343)
2011 (7527)
2010 (7015)
Location
Africa (330)
Alabama (36)
Alaska (4)
Arizona (101)
Arkansas (4)
Asia (11764)
Australia (2046)
California (3957)
Canada (1239)
China (371)
Colorado (203)
Connecticut (121)
Delaware (205)
Europe (30794)
Florida (576)
Georgia (121)
Hawaii (2)
Idaho (12)
Illinois (272)
India (45)
Indiana (318)
Iowa (13)
Japan (215)
Kansas (46)
Kentucky (14)
Louisiana (10)
Maine (9)
Maryland (381)
Massachusetts (3235)
Michigan (146)
Minnesota (204)
Mississippi (5)
Missouri (50)
Montana (6)
Nebraska (10)
Nevada (32)
New Hampshire (17)
New Jersey (1176)
New Mexico (16)
New York (1314)
North Carolina (640)
North Dakota (10)
Northern California (2109)
Ohio (134)
Oklahoma (11)
Oregon (21)
Pennsylvania (659)
Puerto Rico (10)
Rhode Island (16)
South America (393)
South Carolina (12)
Southern California (1384)
Tennessee (77)
Texas (572)
United States (14722)
Utah (84)
Vermont (1)
Virginia (109)
Washington D.C. (31)
Washington State (320)
West Virginia (1)
Wisconsin (91)
Wyoming (1)
209,136 Results for "myovant sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Insights
What makes life science angel investment work?
In this episode of Denatured, you’ll be hearing from Yaniv Sneor, founder of the Mid Atlantic Bio Angels and Alex Pederson, an investor at Mid Atlantic Bio Angels and partner at Alloy Bio Consulting. We discuss why a life sciences-only angel group matters, how they evaluate opportunities, and the importance of strong teams, capital efficiency and a realistic path to exit.
April 30, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Job Trends
Employment and funding growth fell in 2025: California Life Sciences report
California life sciences jobs declined 1.8% last year, according to the new California Life Sciences sector report. While National Institutes of Health funding and venture capital investment rose, their growth slowed from the previous year.
May 15, 2026
·
2 min read
·
Angela Gabriel
Deals
Sumitovant Biopharma Completes Acquisition of Myovant Sciences
Sumitovant Biopharma Ltd. (“Sumitovant”) and Myovant Sciences Ltd. (“Myovant”) announced today that Sumitovant has successfully completed its acquisition of Myovant originally announced October 23, 2022.
March 10, 2023
·
5 min read
Job Trends
Life sciences still falls short on pay equity
Women and nonwhite racial/ethnic groups are still earning less in the life sciences. An industry consultant discusses the pay disparities, ways to fix the gaps and why change is needed.
April 23, 2026
·
5 min read
·
Angela Gabriel
Sponsored
Turn health data into impact: Browns University’s online master in biostatistics & health data science
Trained biostatisticians play a central role in clinical science and public health. Brown’s online master’s in biostatistics (health data science concentration), prepares you with a strong foundation in biostatistical and data science methods combined with rigorous training in applied skills to make critical data-driven decisions and meet the growing demand for leaders in this industry – on your schedule
April 27, 2026
·
3 min read
Job Trends
Washington’s life sciences jobs continue increasing, up 50% from 2014-2024: report
While life sciences employment was down 0.3% nationally in 2024, it rose 1.9% in Washington, according to a new Life Science Washington report. The association’s CEO discusses the latest findings and how the state’s job market looks this year.
April 23, 2026
·
3 min read
·
Angela Gabriel
Job Trends
Could biotech layoffs push life sciences talent to go global?
Amidst rising layoffs in key biotech hubs, global demand for specialized life sciences talent is driving a more borderless, distributed model of scientific work.
April 15, 2026
·
6 min read
·
Joanna Hart
Job Trends
Beyond the Cornfields, Indiana’s Life Sciences Industry Grows Tall
With thousands of companies and a $102 billion impact on the state’s economy, Indiana’s life sciences industry is making its mark. The president and CEO of the Indiana Life Sciences Association discusses the sector’s upside, challenges and where it’s headed in the future.
March 26, 2026
·
5 min read
·
Angela Gabriel
Biotech Bay
Myovant Sciences to Participate at Upcoming September 2022 Investor Conferences
Myovant Sciences announced that David Marek, Chief Executive Officer of Myovant Sciences, Inc., and Uneek Mehra, Chief Financial and Business Officer, will participate in the following upcoming investor conferences.
September 2, 2022
·
2 min read
Business
Myovant Sciences Cancels Second Quarter Earnings Conference Call
Myovant Sciences (NYSE: MYOV) (“Myovant”) today announced the cancellation of its earnings conference call for the quarter ended September 30, 2022 that had originally been scheduled for October 26, 2022 at 5:00 p.m. Eastern Time.
October 24, 2022
·
1 min read
1 of 20,914
Next